Tag: Prescription Drugs
Immediate Start of ART for HIV May Impact 10-Year Risk for Cancer
Deferral of antiretroviral therapy may lead to small increase in risk for AIDS-defining cancer
Donanemab Studied in Early Symptomatic Alzheimer Disease
Slightly less cognitive and functional decline seen with donanemab versus placebo at 76 weeks in phase 2 trial
Prescribing of Psychotropic Meds Up in Nursing Homes During COVID-19
Compared with Jan. to Feb. 2020, prescriptions for antipsychotics, antidepressants, trazodone up from March to Sept. 2020
Review: ß-Blocker Therapy Not Linked to Depression
ß-blocker therapy possibly associated with unusual dreams, insomnia, and sleep disorders
2021 KDIGO Guideline Lowers Target Systolic BP for Adults With CKD
69.5 percent of adults with CKD eligible for BP lowering according to 2021 KDIGO guideline versus 49.8 percent with 2012 guideline
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
Teplizumab Could Delay Diagnosis of Type 1 Diabetes
Teplizumab improves beta-cell function in high-risk individuals with relatives who have type 1 diabetes
Tocilizumab Use Not Supported for Moderate-to-Severe COVID-19
Progression of COVID-19 up to day 14 did not differ with addition of tocilizumab to standard care in Phase 3 trial conducted in India
CNS-Active Polypharmacy Examined in Seniors With Dementia
Most common medication was gabapentin, which was linked to 33.0 percent of polypharmacy-days
AAN: Fetal Exposure to Antiseizure Meds Has No Neuropsychological Impact
No difference found in primary outcome of Verbal Index score at age 3 years with fetal exposure to ASM or for those born to healthy women
